<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Aspirantskiy Vestnik Povolzhiya</journal-id><journal-title-group><journal-title xml:lang="en">Aspirantskiy Vestnik Povolzhiya</journal-title><trans-title-group xml:lang="ru"><trans-title>Аспирантский вестник Поволжья</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2072-2354</issn><issn publication-format="electronic">2410-3764</issn><publisher><publisher-name xml:lang="en">Samara State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">24263</article-id><article-id pub-id-type="doi">10.17816/2072-2354.2016.0.1-2.75-81</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">СOMPARATIVE ANALYSIS OF THE RELATIONSHIP OF CLINICAL AND LABORATORY DATA WITH THE OUTCOME OF SEPSIS IN ICU</article-title><trans-title-group xml:lang="ru"><trans-title>СРАВНИТЕЛЬНЫЙ АНАЛИЗ ВЗАИМОСВЯЗИ КЛИНИКО-ЛАБОРАТОРНЫХ ДАННЫХ С ИСХОДОМ СЕПСИСА В ОРИТ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>KEZKO</surname><given-names>Ju L</given-names></name><name xml:lang="ru"><surname>КЕЦКО</surname><given-names>Ю Л</given-names></name></name-alternatives><email>Kezko-motor@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>LUNINA</surname><given-names>A V</given-names></name><name xml:lang="ru"><surname>ЛУНИНА</surname><given-names>А В</given-names></name></name-alternatives><email>lav21061981@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>GUSYAKOVA</surname><given-names>O A</given-names></name><name xml:lang="ru"><surname>ГУСЯКОВА</surname><given-names>О А</given-names></name></name-alternatives><email>apkrf2@rambler.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>TRUKHANOVA</surname><given-names>I G</given-names></name><name xml:lang="ru"><surname>ТРУХАНОВА</surname><given-names>И Г</given-names></name></name-alternatives><email>innasmp@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Самарский государственный медицинский университет</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2016-03-15" publication-format="electronic"><day>15</day><month>03</month><year>2016</year></pub-date><volume>16</volume><issue>1-2</issue><issue-title xml:lang="en">NO1-2 (2016)</issue-title><issue-title xml:lang="ru">№1-2 (2016)</issue-title><fpage>75</fpage><lpage>81</lpage><history><date date-type="received" iso-8601-date="2020-03-11"><day>11</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2016, KEZKO J.L., LUNINA A.V., GUSYAKOVA O.A., TRUKHANOVA I.G.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2016, КЕЦКО Ю.Л., ЛУНИНА А.В., ГУСЯКОВА О.А., ТРУХАНОВА И.Г.</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="en">KEZKO J.L., LUNINA A.V., GUSYAKOVA O.A., TRUKHANOVA I.G.</copyright-holder><copyright-holder xml:lang="ru">КЕЦКО Ю.Л., ЛУНИНА А.В., ГУСЯКОВА О.А., ТРУХАНОВА И.Г.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://aspvestnik.ru/2410-3764/article/view/24263">https://aspvestnik.ru/2410-3764/article/view/24263</self-uri><abstract xml:lang="en"><p>Objective. The study aims to analyze the dynamic relationship of clinical and laboratory data of patients with sepsis and the outcome in an intensive care unit. Materials and methods. A retrospective analysis of 108 case histories of patients with sepsis was made. The average age of patients was 50,5 ± 15,5 (maximum 77 y.o., minimum 21 y.o.). Men accounted for 58% of all incoming patients. 29 patients were in the state of septic shock. On admission the state of 69 patients resulted from abdominal surgical pathology, 25 suffered from severe soft tissue infection, 10 patients had nosocomial pneumonia, 4 patients had angiogenic catheter infection. Relative mortality rate was 32.4%. Criteria included into the integrated severity scales SOFA and SAPS II were studied. Taking into consideration the current studies [10-12, 45-53] the importance of the following laboratory parameters - the rate of lymphocytes, thromboelastography index and Pct level were investigated. Results. The multiple regression analysis in the common group and the group of survived patients with sepsis taking into account the dependent variable of the disease outcome in the ICU and the hospital bed-day in the ICU showed early significant changes in hemostasis which required timely correction. Нypercoagulable syndrome, thrombocytopenia initiation, activation of secondary fibrinolysis are characteristic of the survived patients. Hyperfibrinolysis with the normo- and hypocoagulation syndrome, progressive thrombocytopenia are observed in the common group of patients. Conclusion. Nonspecific clinical symptoms of sepsis necessitate the choice of early laboratory sepsis markers in order to initiate the timely targeted therapy. Dynamics of hemostasis, identified by thromboelastography is the early predictor of sepsis. They characterize the worsening thrombinemia. Valid additional criteria of unfavorable sepsis outcome in order of importance were the percentage of lymphocytes, leukocytosis and procalcitonin levels.</p></abstract><trans-abstract xml:lang="ru"><p>Цель исследования. Произвести анализ динамической взаимосвязи клинико-лабораторных данных пациентов с сепсисом и исходом в условиях ОРИТ. Материалы и методы. Произведен ретроспективный анализ 108 историй болезни пациентов с сепсисом. Средний возраст пациентов - 50,5±15,5 (максимум - 77, минимум - 21 год). Мужчины составили 58% от всех поступивших пациентов. В состоянии септического шока находилось 29 больных. По входным воротам: у 69 больных причинным фактором была абдоминальная хирургическая патология, у 25 - тяжелые инфекции мягких тканей, 10 пациентов с нозокомиальной пневмонией, у 4 пациентов - ангиогенная катетерная инфекция. Относительная летальность в исследуемой группе составила 32,4%. В качестве исследуемых признаков выступали критерии, входящие в интегральные шкалы тяжести SOFA и SAPS II. Исходя из современных исследований [11-13, 28-36], дополнительно изучалась значимость лабораторных показателей: процент лимфоцитов, уровень Pct и показатели тромбоэластографии. Результаты. Проведенный множественный регрессионный анализ в общей группе и в группе выживших больных с сепсисом с зависимой переменной соответственно - исход заболевания в ОРИТ и койко/день в ОРИТ показал ранние значимые изменения в гемостазе, требующие своевременной коррекции. Для группы выживших пациентов: гиперкоагуляционный синдром, инициация тромбоцитопении, активация вторичного фибринолиза. Для общей группы больных: гиперфибринолиз с нормо-и гипокоагуляционным синдромом, прогрессивная тромбоцитопения. Заключение. Неспецифичность клинических симптомов сепсиса диктует необходимость выбора ранних лабораторных маркеров сепсиса с целью своевременной целенаправленной терапии. Динамика показателей гемостаза, выявляемая методом тромбоэластографии, является ранними предикторами сепсиса. Они характеризуют нарастающую тромбинемию. Достоверными дополнительными критериями неблагоприятного исхода сепсиса по значимости были процент лимфоцитов, уровень лейкоцитоза и прокальцитонина.</p></trans-abstract><kwd-group xml:lang="en"><kwd>sepsis</kwd><kwd>mortality</kwd><kwd>clinical and laboratory criteria</kwd><kwd>hemostasis</kwd><kwd>thromboelastography</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>Сепсис</kwd><kwd>летальность</kwd><kwd>клинические и лабораторные критерии</kwd><kwd>гемостаз</kwd><kwd>тромбоэластография</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Маренко В.А. Информационно-синергетический подход к анализу медицинских данных // Медицинская информатика. - 2009. - № 2 (20). - С.33-38.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Adamzik M., Eggmann M., Frey U.H., Gorlinger K., Brocker-Preuss M., Marggraf G., Saner F., Eggebrecht H., Peters J., Hartmann M. Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adults // Crit Care. - 2010. - 14. - R178.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Biomarkers Definitions Working Group: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework //Clin. Pharmacol. Ther. - 2001. - 69. - Р.89-95.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Brenner T., Schmidt K., Delang M., Mehrabi A., Bruckner T., Lichtenstern C., Martin E., Weigand M.A., Hofer S. Viscoelastic and aggregometric point-of-care testing in patients with septic shock - cross-links between inflammation and haemostasis. Acta Anaesthesiol Scand. - 2012. - 56. - Р.1277-1290.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Pierrakos C., Vincent J.L. Sepsis biomarkers: a review The electronic version of this article is the complete one and can be found online at: http://ccforum.com/content/14/1/R15.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Cavallazzi R, Bennin CL, Hirani A, Gilbert C, Marik PE: Is the band count useful in the diagnosis of infection? An accuracy study in critically ill patients. J Intensive Care Med. - 2010. - 25. - Р.353-357.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Chiairi F., Ickx B., Barvais L., Vincent J-L, Piagnerelli M. Does activated protein C influence the coagulation system assessed by the rotative thromboelastometry analysis [abstract] // Intensive Care Med. - 2009. - Conference: Р.162.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Collins P.W., Macchiavello L.I., Lewis S.J., Macartney N.J., Saayman A.G., Luddington R., Baglin T., Findlay G.P. Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls // Br. J. Haematol. - 2006. - 135. - Р.220-227.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Drake T.A., Cheng J., Chang A., Taylor F.B. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis // Am. J. Pathol. - 1993. - 142. - Р.1458-1470.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Durila M., Bronsky J., Harustiak T., Pazdro A., Pechova M., Cvachovec K. Early diagnostic markers of sepsis after oesophagectomy (including thromboelastography) // BMC Anesthesiol. - 2012. - 12:12.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Fisher C.J. Jr, Yan S.B.: Protein C. levels as a prognostic indicator of outcome in sepsis and related diseases // Crit Care Med. - 2000. - 28. - Р.49-56.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Heuer J.G., Sharma G.R., Gerlitz B., Zhang T., Bailey D.L., Ding C., Berg D.T., Perkins D., Stephens E.J., Holmes K.C., Grubbs R.L., Fynboe K.A., Chen Y.F., Grinnell B., Jakubowski J.A. Evaluation of protein C and other biomarkers as predictors of mortality in a rat cecal ligation and puncture model of sepsis // Crit Care Med. - 2004. - 32. - Р.1570-1578.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Kinasewitz G.T., Yan S.B., Basson B., Comp P., Russell J.A., Cariou A., Um S.L., Utterback B., Laterre P.F., Dhainaut J.F. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569] // Crit Care. - 2004. - 8. - Р.82-90.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Kumar A., Roberts D., Wood K.E., Light B., Parrillo J.E., Sharma S., Suppes R., Feinstein D., Zanotti S., Taiberg L., Gurka D., Kumar A., Cheang M. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock // Crit Care Med. - 2006. - 34. - Р.1589-1596.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Lever A., Mackenzie I. Sepsis: definition, epidemiology, and diagnosis // BMJ. - 2007. - 335. - Р.879-883.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Levi M, Meijers JC. DIC: which laboratory tests are most useful. Blood Rev. - 2011. - 25. Р.33-37.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Lin S.M., Wang Y.M., Lin H.C., Lee K.Y., Huang C.D., Liu C.Y., Wang C.H., Kuo H.P. Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis // Crit Care Med. - 2008. - 36. - Р.683-689.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Madoiwa S., Nunomiya S., Ono T., Shintani Y., Ohmori T., Mimuro J., Sakata Y.: Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsisinduced isseminated intravascular coagulation // Int. J. Hematol. - 2006. - 84. - Р.398-405.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Marshall J.C., Reinhart K.: Biomarkers of sepsis. Crit Care Med. - 2009. - 37. - Р.2290-2298.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Massion P.B., Peters P., Ledoux D, Zimermann V., Canivet J.L., Massion P.P., Damas P., Gothot A. Persistent hypocoagulability in patients with septic shock predicts greater hospital mortality: impact of impaired thrombin generation // Intensive Care Med. - 2012. - 38. - Р.1326-1335.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Nobre V., Harbarth S., Graf J.D., Rohner P., Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial // Am J Respir Crit Care Med. - 2008. - 177. - Р.498-505.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Ostrowski S.R., Windelov N.A., Ibsen M., Haase N., Perner A., Johansson P.I. Consecutive thrombelastography clot strength profiles in patients with severe sepsis and their association with 28-day mortality: a prospective study. J. Crit Care 2013. - 28. - Р.317.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Marik P.E. Don’t miss the diagnosis of sepsis! // Critical Care 2014 18:529.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Pettila V., Pentti J., Pettila M., Takkunen O., Jousela I.: Predictive value of antithrombin III and serum C-reactive protein concentration in critically ill patients with suspected sepsis // Crit Care Med. - 2002. - 30. - Р.271-275.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Pralong G., Calandra T., Glauser M.P., Schellekens J., Verhoef J., Bachmann F., Kruithof E.K. Plasminogen activator inhibitor 1: a new prognostic marker in septic shock // Thromb. Haemost. - 1989. - 61. - Р.459-462.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Raineri S.M., Cangemi L., Cortegiani A., Cascio N.D., Mineo G., Evangelico G., Giarratano A.: Fibrinolysis system, monitored by thromboelastography (TEG) and PAI-1 activity, in septic patients undergoing tight glycemic control [abstract] // Intensive Care Med. - 2009. - Conference: S162.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Rangel-Frausto M.S, Wenzel R.P. The epidemiology and natural history of bacterial Sepsis // В книге: Sepsis and multiorgan failure. Ed 1997. - Р.27-34.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Gando S., Saitoh D. A multicenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis Critical Care. - 2013. - 17:R111 doi:10.1186/cc12783</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Karlsson S., Heikkinen M. Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study Critical Care. - 2010. - 14:R205 doi:10.1186/cc9327</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Society of Critical Care Medicine, European Society of Intensive Care Medicine 2013. www.survivingsepsis.org // Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Su C.P., Chen T.H., Chen S.Y., Ghiang W.C., Wu G.H., Sun H.Y., Lee C.C., Wang J.L., Chang S.C., Chen Y.C., Yen A.M., Chen W.J., Hsueh P.R. Predictive model for bacteremia in adult patients with blood cultures performed at the emergency department: a preliminary report // J. Microbiol Immunol Infect. - 2011. - 44. - Р.449-455.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Tang B.M., Eslick G.D., Craig J.C., McLean A.S.: Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis // Lancet Infect Dis. - 2007. - 7. - Р.210-217.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Tromp M., Lansdorp B., Bleeker-Rovers C.P., Gunnewiek J.M., Kullberg B.J., Pickkers P. Serial and panel analyses of biomarkers do not improve the prediction of bacteremia compared to one procalcitonin measurement // J. Infect. - 2012. - 65. - Р.292-301.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Umgelter A., Msmer G., Schmid R.M., Kreymann B. Thromboelastography and platelet function assay in cirrhosis and sepsis [abstract] // Intensive Care Med. - 2009. - Conference: S160.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Wacker C., Prkno A., Brunkhorst F.M., Schlattmann P. Procalcitonin as adiagnostic marker for sepsis: a systematic review and meta-analysis // Lancet Infect Dis. - 2013. - 13. - Р.426-435.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Zakariah A.N., Cozzi S.M., Van Nuffelen M., Clausi C.M., Pradier O., Vincent J.L.: Combination of biphasic transmittance waveform with blood procalcitonin levels for diagnosis of sepsis in acutely ill patients // Crit Care Med. - 2008. - 36. - Р.1507-1512.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Zambon M., Ceola M., Almeida-de-Castro R., Gullo A., Vincent J.L. Implementation of the Surviving Sepsis Campaign guidelines for severe sepsis and septic shock: we could go faster // J. Crit Care. - 2008. - 23. - Р.455-460.</mixed-citation></ref></ref-list></back></article>
